Sometimes, scientific data is presented that to a patient is patently obvious. But bringing scientific rigor to seemingly obvious things can still be useful.
New analyses of clinical trials of Enbrel (etanercept) for psoriasis and psoriatic arthritis and Stelara (ustekinumab) for psoriasis found that both biologics reduced patients’ symptoms of anxiety and depression, and improved their
READ THE FULL POST
|
|||||||||||||
|
